Ian Davis

Be Careful Not To ARAMIS the Point.

Ian D Davis

Journal article  |  2023  |  Eur Urol

Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.

Ziad Bakouny, Talal El Zarif, Shaan Dudani, J Connor Wells, Chun Loo Gan, Frede Donskov, Julia Shapiro, Ian D Davis, Francis Parnis, Praful Ravi, John A Steinharter, Neeraj Agarwal, Ajjai Alva, Lori Wood, Anil Kapoor, Jose M Ruiz Morales, Christian Kollmannsberger, Benoit Beuselinck, Wanling Xie, Daniel YC Heng, et al.

Journal article  |  2023  |  Eur Urol

BACKGROUND: The role of upfront cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) in the era of immune che..

Adding Mitomycin to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive -bladder cancer: A randomised phase 3 trial: The BCG MM Study (ANZUP1301)

D Hayne, M Stockler, AJ Martin, S Mccombie, D Zebic, L Krieger, P Anderson, P Bastick, E Beardsley, A Blatt, M Frydenberg, W Green, J Grummet, C Hawks, J Ischia, A Mitterdorfer, M Patel, M Roberts, S Sengupta, R Srivastav, et al.

Journal article  |  2023  |  European Urology

PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [Lu-177]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, 2 trial

James P Buteau, Andrew J Martin, Louise Emmett, Amir Iravani, Shahneen Sandhu, Anthony M Joshua, Roslyn J Francis, Alison Y Zhang, Andrew M Scott, Sze-Ting Lee, Arun A Azad, Margaret M McJannett, Martin R Stockler, Scott G Williams, Ian Davis, Michael S Hofman

Journal article  |  2022  |  LANCET ONCOLOGY

BACKGROUND: Previously, results from the TheraP trial showed that treatment with lutetium-177 [177Lu]Lu-PSMA-617 improved frequenc..

WATIP: A pilot study of water irrigation post TURBT for preventing recurrence of NMIBC

Mo Li, Ian Davis, Shomik Sengupta

Conference Proceedings  |  2022  |  INTERNATIONAL JOURNAL OF UROLOGY

Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anti-cancer treatment: a multi-centre, open-label, randomised controlled trial

WK Soo, M King, A Pope, P Parente, P Dārziņš, I Davis

Journal article  |  2022  |  Journal of Geriatric Oncology

Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial.

Wee Kheng Soo, Madeleine T King, Alun Pope, Phillip Parente, Pēteris Dārziņš, Ian D Davis

Journal article  |  2022  |  Lancet Healthy Longev

BACKGROUND: The effectiveness of comprehensive geriatric assessment (CGA) in improving health outcomes in cancer settings is uncle..

PSMA and FDG PET as Predictive and Prognostic Biomarkers in Men with Metastatic, Castration-Resistant Prostate Cancer (mCRPC): an Analysis of the Randomised, Phase 2 Trial of [Lu-177]Lu-PSMA-617 Versus Cabazitaxel (TheraP, ANZUP 1603)

J Buteau, A Martin, L Emmett, A Iravani, S Sandhu, AM Joshua, RJ Francis, AY Zhang, AM Scott, S Lee, A Azad, M McJannett, MR Stockler, S Williams, ID Davis, MS Hofman

Conference Proceedings  |  2022  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

1735O PD-L1 expression on immune cells by SP142 co-localises with dendritic cells and is associated with improved overall survival (OS) with atezolizumab in patients with untreated metastatic urothelial cancer (mUC)

E Grande Pulido, MD Galsky, R Van Elzen, R Banchereau, M Peterson, C Sedano, H Koeppen, H Li, A Bamias, JA Arranz Arija, E Kikuchi, M De Santis, ID Davis, I Mellman, S Oh, P Williams, S Bernhard, CP Lee, M Kockx, S Mariathasan

Journal article  |  2022  |  Annals of Oncology

1739P Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: Analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502)

AJ Weickhardt, F Foroudi, J Xie, K Kanojia, M Sidhom, A Pal, P Grimison, A Zhang, S Ng, C Tang, E Hovey, C Chen, G Hruby, A Guminski, M Mcjannett, CJ Conduit, N Lawrentschuk, B Tran, ID Davis, D Hayne

Journal article  |  2022  |  Annals of Oncology